Sprint Bioscience appoints new CEO

Sprint Bioscience announces Erik Kinnman as new CEO of the company. He has 25 years of experience from leading positions in the pharmaceutical and biotechnology industry.

“We are very pleased to welcome Erik Kinnman as the new CEO of Sprint Bioscience. His extensive experience from leading positions in global pharmaceutical companies, solid scientific background, and thorough understanding of the capital market give him excellent qualifications to lead the company in its further development. I would also like to extend a big thank you to Charlotte Leife for her significant efforts during her time as Acting CEO”, says Sprint Biosciences’ Chairman of the Board, Rune Nordlander.

Erik Kinnman will take up the role on March 1 and succeed Charlotte Leife, who has been acting CEO since September 1, 2021.

Kinnman was between 2016 and January 2021 CEO of Abliva AB (formerly Neurovive), a biotechnology company listed on Nasdaq Stockholm’s Main Market. Prior to that, he held senior positions at AstraZeneca and SOBI and was also active as a financial analyst at Danske Bank. Erik Kinnman is a physician, Doctor of Medicine, and associate professor at Karolinska Institutet. He has a specialist education in neurology and pain relief, as well as an Executive MBA from the Stockholm School of Economics.

More information in this press release.

Matti Sällberg: “Vital to contribute facts to the debate”

During the course of the pandemic, he has appeared on an almost daily basis in the morning papers or on the TV news. Matti Sällberg fast became an expert the media called for help explaining everything from vaccine development to the spread of infection.

Sprint Bioscience appoints new CEO

Sprint Bioscience announces Erik Kinnman as new CEO of the company. He has 25 years of experience from leading positions in the pharmaceutical and biotechnology industry.

Matti Sällberg: “Vital to contribute facts to the debate”

During the course of the pandemic, he has appeared on an almost daily basis in the morning papers or on the TV news. Matti Sällberg fast became an expert the media called for help explaining everything from vaccine development to the spread of infection.

Vill du veta mer?
Prenumerera på vårt nyhetsbrev.

PRENUMERERA

Vill du veta mer?
Prenumerera på vårt nyhetsbrev.

PRENUMERERA
CF_logo_neg
2021-03-12T10:47:22+01:00
Go to Top